Eli Lilly Cymbalta Promotion Stopped by FDA

The FDA has demanded that Eli Lilly and Co cease a promotion for their psych drug Cymbalta because it makes misleading claims and understates risk.

Apparently Eli Lilly forgot to mention in its promotion that amongst other things Cymbalta causes liver toxicity. Is this just a one off wrist slap to keep up appearances… or is the FDA serious about starting to do its job?

If it is the latter it is incredibly good news and signals the start of the stop of the Psych/Big Pharma social rot.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: